32
2
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T6812L | Cyclo(-RGDfK) TFA | Integrin | |
Cyclo(-RGDfK) is a selective αvβ3 integrin inhibitor(IC50 : 0.94 nM). | |||
T6812 | Cyclo(-RGDfK) | Cyclo (-RGDfK) | Integrin |
Cyclo(-RGDfK) (Cyclo (-RGDfK)) is an effective and specific αvβ3 integrin inhibitor. | |||
TP1474 | LXW7 | Integrin | |
LXW7 is an octamer disulfide cyclic peptide and αvβ3 integrin ligand, acts as a potent and specific endothelial progenitor cells (EPCs) and endothelial cells (ECs) targeting ligand. LXW7 is a disulfide cyclic octa-pepti... | |||
TP1879L1 | P11 acetate | Integrin | |
P11 acetate is an integrin αvβ3-vitronectin interaction antagonist(IC50 = 2.74 nM). | |||
T6813 | Cyclo(RGDyK) trifluoroacetate | Cyclo(RGDyK) | Integrin |
Cyclo(RGDyK) trifluoroacetate is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM. | |||
T6657 | SB273005 | Integrin | |
SB273005 is a potent integrin inhibitor with Ki of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively. | |||
T2494 | Cilengitide | EMD 121974 | Integrin , Autophagy |
Cilengitide (EMD 121974) is a potent integrin inhibitor for the αvβ3/5 receptor (IC50: 4.1/79 nM, in cell-free assays); ~10-fold selectivity against gpIIbIIIa. | |||
TP1459L | Gly-Arg-Gly-Asp-Ser acetate(96426-21-0 free base) | Integrin | |
Gly-Arg-Gly-Asp-Ser (GRGDS) acetate is a cell binding protein domain derived from the cell-binding region of fibronectin. | |||
TP2148 | LXW7 TFA (1313004-77-1 free base) | LXW7 TFA | Integrin |
LXW7 TFA, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin αvβ3 inhibitor with an anti-inflammatory effect. LXW7 has a high binding affinity to αvβ3 integrin (IC50: 0.68 μM). It increases the phosphorylation... | |||
T16085 | MK-0429 | L-000845704 | Others |
MK-0429 is an orally active, selective, and nonpeptide antagonist of αvβ3 integrin (IC50: 80 nM). | |||
TQ0250 | CWHM-12 | Integrin | |
CWHM-12 is a potent inhibitor of αV integrins (IC50s of 0.2/0.8/1.5/1.8 nM for αvβ8/αvβ3/αvβ6/αvβ1). | |||
TP2390 | Maraciclatide | NC-100692,NC 100692,NC100692 | |
Maraciclatide is a radiopharmaceutical targeting αvβ3 integrin. | |||
T8726 | Cyclo(RGDyK) | Integrin | |
Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM. | |||
T15584 | Integrin Antagonists 27 | Others | |
Integrin Antagonists 27 is a small molecule integrin αvβ3 antagonist. It has a binding affinity of 18 nM and as a novel anticancer agent. | |||
T69460 | TSRI265 | ||
TSRI265 is a novel αvβ3 ligand, disrupting the integrin-MMP2 interaction and showing antiangiogenic activit, inhibiting angiogenesis and tumor growth in vivo. | |||
T11663 | Integrin-IN-2 | Others | |
T68462 | D-Ornithine lactam | ||
D-Ornithine lactam is a building block. It has been used in the synthesis of hepatitis C virus non-structural protein 5B inhibitors, as well as αVβ3 integrin receptor antagonists. | |||
T75724 | LXW7 TFA | ||
LXW7 TFA, a cyclic peptide encompassing Arg-Gly-Asp (RGD), serves as an inhibitor of integrin αvβ3. It demonstrates high binding affinity towards αvβ3 integrin, evidenced by an IC50 value of 0.68 μM. Additionally, LXW7 T... | |||
TP1879 | HSDVHK-NH2 | P11 | |
Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic. | |||
T6806 | Cilengitide TFA | Integrin , Autophagy | |
Cilengitide is a potent integrin inhibitor for αvβ3 receptor and αvβ5 receptor with IC50 of 4.1 nM and 79 nM in cell-free assays, respectively; ~10-fold selectivity against gpIIbIIIa. Phase 2. | |||
T10920 | Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA | Others | |
Arg-Gly-Asp-D-Phe-Val (TFA) has anti-tumor activity and is an inhibitor of integrin αvβ3. | |||
T75835 | HSDVHK-NH2 TFA | ||
HSDVHK-NH2 TFA acts as an antagonist to the αvβ3-vitronectin integrin interaction, displaying an inhibitory concentration (IC 50) of 1.74 pg/mL (2.414 pM) [1] [2]. | |||
T75990 | Cyclo(Arg-Gly-Asp-D-Phe-Val) | ||
Cyclo(Arg-Gly-Asp-D-Phe-Val) is an integrin αvβ3 inhibitor with antitumor properties, utilized in the research of acute myeloid leukemia [1]. | |||
T76807 | Etaracizumab | ||
Etaracizumab (LM 609), an αvβ3 integrin IgG1 monoclonal antibody, effectively inhibits angiogenesis and melanoma tumor growth, offering a potential avenue for anticancer research [1]. | |||
T74400 | TC113 | ||
TC113, a Gemcitabine (GEM)-based conjugate incorporating the c(RGDyK) sequence, is internalized by A549 cells via the integrin αvβ3 pathway. It demonstrates significant antiproliferative effects on both WM266.4 and A549 ... | |||
TP2098 | Echistatin | Echistatin, α1 isoform | |
Potent irreversible αVβ3 integrin antagonist (Ki = 0.27 nM). Disrupts attachment of osteoclasts to bone and inhibits bone reabsorption (IC50 = 0.1 nM). Prevents ADP-induced platelet aggregation via inhibition of glycopro... | |||
T78064 | Synstatin (92-119) | SSTN92-119 | Integrin |
Synstatin (92-119) serves as an anti-tumor agent by suppressing angiogenesis and cancer cell invasion, chiefly through the down-regulation of integrin αvβ3 and attenuation of angiogenic growth factor activation, specific... | |||
T82516 | E(c(RGDfK))₂ | ||
E(c(RGDfK)) is an αvβ3 integrin-specific binding moiety with tumor-targeting properties, demonstrating increased uptake in human ovarian cancer OVCAR-3 xenograft tumors, suggesting potential utility in cancer research [1... | |||
T75761 | Gly-Arg-Gly-Asp-Ser TFA | GRGDS TFA | |
Gly-Arg-Gly-Asp-Ser (TFA), a pentapeptide comprising the cell-binding domain of osteopontin (a glycoprotein), interacts with integrin receptors αvβ3 and αvβ5, exhibiting respective estimated IC50 values of approximately ... | |||
T76068 | Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA | ||
Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA (Cyclo RGDfC) TFA, a cyclic RGD peptide, displays a high affinity for αvβ3 integrin, effectively disrupting cell-integrin interactions. It suppresses pluripotent marker expression in embr... | |||
TP1974 | Obtustatin | ||
Highly potent integrin α1β1 inhibitor (IC50 = 0.8 nM for α1β1 binding to type IV collagen). Selective for α1β1 over α2β1, αIIbβ3, αvβ3, α4β1, α5β6, α9β1 and α4β7. Inhibits FGF2-stimulated angiogenesis in the chicken chor... | |||
T83736 | RTDLDSLRTYTL TFA | ||
RTDLDSLRTYTL is a ligand for αVβ6 integrin, exhibiting selective inhibition of fibronectin's binding to αVβ6 integrin with considerably less effect on the interactions between vitronectin and αVβ3 or αVβ5, as well as fib... |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T36715 | Tetrac | Tetraiodothyroacetic acid,3,3',5,5'-Tetraiodothyroacetic acid | Apoptosis , EGFR |
Tetrac (Tetraiodothyroacetic acid) is a derivative of L-thyroxine (T4), a thyroxine integrin receptor antagonist.Tetrac induces antiproliferation by blocking EGFR-mediated cell signaling in colorectal cancer cells.Tetrac... | |||
T36295 | Echistatin TFA | ||
Echistatin TFA, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation. Echistatin is a potent inhibitor of bone resorpti... |